文献速递主动脉疾病外周动脉疾病

衰弱对老年患者大血管手术后结局的影响:系统综述与Meta分析

The Impact of Frailty on Outcomes of Elderly Patients After Major Vascular Surgery: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-08-16

该系统综述与Meta分析检索了截至2018年5月12日的多个数据库,纳入22项队列研究和1项随机对照试验,评估衰弱对血管手术后短期和长期结局的影响。结果显示,衰弱与30天死亡率(OR 3.83,95%CI 3.08-4.76)和长期全因死亡率(HR 2.22,95%CI 1.81-2.73)风险显著增加相关;功能状态是唯一具有高质量证据预测30天死亡率的工具,中央肌肉量是唯一具有中等质量证据预测长期生存的工具。作者认为,衰弱评估可考虑用于计划接受血管手术的患者。

要点

  • 衰弱与血管手术后30天死亡率风险显著增加相关(OR 3.83,95%CI 3.08-4.76)。
  • 功能状态是唯一具有高质量证据预测30天死亡率的工具(OR 4.49,95%CI 3.81-5.30)。
  • 中央肌肉量是唯一具有中等质量证据预测长期生存的工具(HR 2.48,95%CI 1.76-3.49)。

核心结论

  • 通过功能状态评估的衰弱可以预测老年患者血管手术后的短期死亡率;中央肌肉量可能有助于判断腹主动脉修复术后的长期生存。
  • 由于衰弱与短期和长期结局较差均相关,对计划接受血管手术的患者可考虑进行衰弱评估。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase、Cochrane数据库和Scopus(更新至2018年5月12日),纳入22项队列研究和1项随机对照试验。
  • 使用改良纽卡斯尔-渥太华量表评估纳入研究的质量,采用随机效应模型计算比值比(OR)或风险比(HR)。

主要发现

  • 总体衰弱与血管手术后30天死亡率风险显著增加相关(OR 3.83,95%CI 3.08-4.76),在腹主动脉瘤修复术患者(OR 5.15,95%CI 3.91-6.77)和下肢血运重建术患者(OR 3.29,95%CI 2.53-4.28)中效果相似。
  • 功能状态是唯一具有高质量证据预测血管手术后30天死亡率的工具(OR 4.49,95%CI 3.81-5.30)。
  • 衰弱与总体研究人群的长期全因死亡率风险显著增加相关(HR 2.22,95%CI 1.81-2.73),在腹主动脉瘤修复术患者(HR 2.10,95%CI 1.59-2.79)和下肢血运重建术患者(HR 2.46,95%CI 1.73-3.49)中亦如此。
  • 中央肌肉量是唯一具有中等质量证据预测大血管手术后长期生存的工具(HR 2.48,95%CI 1.76-3.49)。
  • 其他单域工具通常评为低质量,改良衰弱指数是唯一具有中等质量的多域工具,其他多域工具评为低或极低质量。

关键数值与推荐

  • 功能状态预测30天死亡率:OR 4.49,95%CI 3.81-5.30,证据质量高。
  • 中央肌肉量预测长期生存:HR 2.48,95%CI 1.76-3.49,证据质量中等。
  • 改良衰弱指数是唯一具有中等证据质量的多域工具。

临床怎么用

  • 作者认为,对计划接受血管手术的患者可考虑进行衰弱评估。
  • 功能状态评估可用于预测老年患者血管手术后的短期死亡率。
  • 中央肌肉量可能有助于判断腹主动脉修复术后的长期生存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the quality of published evidence of all frailty tools in major vascular surgery and to determine the effect of frailty on short and long-term outcomes after vascular procedures. METHODS: MEDLINE, Embase, Cochrane Database and Scopus (updated on May 12, 2018) were searched for studies evaluating the effect of frailty in vascular surgery and data were extracted from the included studies. A modified Newcastle-Ottawa scale was used to assess the quality of the included studies. The impact of frailty on outcomes was expressed as odds ratios (OR) or hazard ratios (HR) using a random effects model. RESULTS: A total of 22 cohort studies and one RCT were included. Overall frailty was found to be associated with a significantly increased risk of 30 day mortality in patients who underwent vascular surgery (OR 3.83, 95% CI 3.08-4.76), with similar effects in both patients who underwent abdominal aortic aneurysm (AAA) repair (OR 5.15, 95% CI 3.91-6.77) and lower extremity revascularisation (OR 3.29, 95% CI 2.53-4.28). Functional status remained the only tool with high quality of evidence predicting 30 day mortality after vascular surgery (OR 4.49, 95% CI 3.81-5.30). As for long-term outcomes, frailty was associated with a significantly increased risk of long-term all cause mortality in the overall studied population (HR 2.22, 95% CI 1.81-2.73), as well as in patients with AAA repair (HR 2.10, 95% CI 1.59-2.79) and lower extremity revascularisation (HR 2.46, 95% CI 1.73-3.49). Central muscle mass was found to be the only tool with moderate quality of evidence predicting long-term survival after major vascular surgery (HR 2.48, 95% CI 1.76-3.49). Other single domain tools were generally scored as low quality, and the modified Frailty Index was the only multi-domain tool with moderate quality while others were scored as low or very low. CONCLUSION: Frailty, assessed by functional status, can predict short-term mortality in elderly patients after vascular surgery; while central muscle mass may help determine long-term survival in abdominal aortic repair. As frailty is associated with both worse short and long-term outcomes, frailty assessment may be considered in patients scheduled for vascular surgery.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang J, Zou Y, Zhao J, et al. The Impact of Frailty on Outcomes of Elderly Patients After Major Vascular Surgery: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2018. PMID: 30122332. doi:10.1016/j.ejvs.2018.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。